 |
PDBsum entry 4u84
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
E.C.5.2.1.8
- peptidylprolyl isomerase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
[protein]-peptidylproline (omega=180) = [protein]-peptidylproline (omega=0)
|
 |
 |
 |
 |
 |
Peptidylproline (omega=180)
|
=
|
peptidylproline (omega=0)
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Molecule diagrams generated from .mol files obtained from the
KEGG ftp site
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
| |
|
DOI no:
|
Neurobiol Dis
76:13-23
(2015)
|
|
PubMed id:
|
|
|
|
|
| |
|
Pin1 cysteine-113 oxidation inhibits its catalytic activity and cellular function in Alzheimer's disease.
|
|
C.H.Chen,
W.Li,
R.Sultana,
M.H.You,
A.Kondo,
K.Shahpasand,
B.M.Kim,
M.L.Luo,
M.Nechama,
Y.M.Lin,
Y.Yao,
T.H.Lee,
X.Z.Zhou,
A.M.Swomley,
D.Allan Butterfield,
Y.Zhang,
K.P.Lu.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
The unique proline isomerase Pin1 is pivotal for protecting against
age-dependent neurodegeneration in Alzheimer's disease (AD), with its inhibition
providing a molecular link between tangle and plaque pathologies. Pin1 is
oxidatively modified in human AD brains, but little is known about its
regulatory mechanisms and pathological significance of such Pin1 modification.
In this paper, our determination of crystal structures of oxidized Pin1 reveals
a series of Pin1 oxidative modifications on Cys113 in a sequential fashion.
Cys113 oxidization is further confirmed by generating antibodies specifically
recognizing oxidized Cys113 of Pin1. Furthermore, Pin1 oxidation on Cys113
inactivates its catalytic activity in vitro, and Ala point substitution of
Cys113 inactivates the ability of Pin1 to isomerize tau as well as to promote
protein turnover of tau and APP. Moreover, redox regulation affects Pin1
subcellular localization and Pin1-mediated neuronal survival in response to
hypoxia treatment. Importantly, Cys113-oxidized Pin1 is significantly increased
in human AD brain comparing to age-matched controls. These results not only
identify a novel Pin1 oxidation site to be the critical catalytic residue
Cys113, but also provide a novel oxidative regulation mechanism for inhibiting
Pin1 activity in AD. These results suggest that preventing Pin1 oxidization
might help to reduce the risk of AD.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
');
}
}
 |